1. Home
  2. CLRB vs LSF Comparison

CLRB vs LSF Comparison

Compare CLRB & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • LSF
  • Stock Information
  • Founded
  • CLRB 2002
  • LSF 2015
  • Country
  • CLRB United States
  • LSF United States
  • Employees
  • CLRB N/A
  • LSF N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • LSF Packaged Foods
  • Sector
  • CLRB Health Care
  • LSF Consumer Staples
  • Exchange
  • CLRB Nasdaq
  • LSF Nasdaq
  • Market Cap
  • CLRB 12.5M
  • LSF 73.2M
  • IPO Year
  • CLRB N/A
  • LSF 2020
  • Fundamental
  • Price
  • CLRB $7.90
  • LSF $6.39
  • Analyst Decision
  • CLRB Hold
  • LSF Strong Buy
  • Analyst Count
  • CLRB 2
  • LSF 2
  • Target Price
  • CLRB N/A
  • LSF $12.00
  • AVG Volume (30 Days)
  • CLRB 1.3M
  • LSF 28.5K
  • Earning Date
  • CLRB 08-12-2025
  • LSF 08-06-2025
  • Dividend Yield
  • CLRB N/A
  • LSF N/A
  • EPS Growth
  • CLRB N/A
  • LSF N/A
  • EPS
  • CLRB N/A
  • LSF N/A
  • Revenue
  • CLRB N/A
  • LSF $45,040,358.00
  • Revenue This Year
  • CLRB N/A
  • LSF $23.40
  • Revenue Next Year
  • CLRB N/A
  • LSF $20.11
  • P/E Ratio
  • CLRB N/A
  • LSF N/A
  • Revenue Growth
  • CLRB N/A
  • LSF 25.04
  • 52 Week Low
  • CLRB $6.50
  • LSF $3.40
  • 52 Week High
  • CLRB $94.50
  • LSF $10.90
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 40.04
  • LSF 46.93
  • Support Level
  • CLRB $9.60
  • LSF $6.03
  • Resistance Level
  • CLRB $10.19
  • LSF $6.51
  • Average True Range (ATR)
  • CLRB 1.57
  • LSF 0.37
  • MACD
  • CLRB -0.50
  • LSF -0.04
  • Stochastic Oscillator
  • CLRB 11.58
  • LSF 40.00

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

Share on Social Networks: